Artículos de revistas sobre el tema "Glioma patients"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Glioma patients".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Jiang, Chongming, Evelien Schaafsma, Yanding Zhao, Thinh Nguyen, Kenneth Zhu y Chao Cheng. "Abstract LB528: A microglia associated gene signature predicts survival risk in glioma patients". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): LB528. http://dx.doi.org/10.1158/1538-7445.am2022-lb528.
Texto completoZhao, Shiguang. "BIOM-63. DIAGNOSIS AND PROGNOSTIC SIGNIFICANCE OF CIRCULATING miR-2276-5p IN PLASMA OF GLIOMA PATIENTS". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii15. http://dx.doi.org/10.1093/neuonc/noaa215.060.
Texto completoLi, shaoqun, Mingyao Lai, Jiangfen Zhou, junjie Zhen y Linbo Cai. "PATH-22. GENETIC VARIATION BETWEEN IDH MUTANT AND IDH WILD-TYPE GLIOMA". Neuro-Oncology 23, Supplement_6 (2 de noviembre de 2021): vi119. http://dx.doi.org/10.1093/neuonc/noab196.474.
Texto completoPriambada, Dody, Muhamad Thohar Arifin, Surya Pratama Briliantika, Dian Widyaningrum, Abdi Saputro, Azka Tajussyarof El Muzakka, Yuriz Bakhtiar, Krisna Tsaniadi Prihastomo y Zainal Muttaqin. "Serum GFAP and EGFR as Supportive Diagnostic Biomarker of Glioma Patients: A Single-Center Study". Open Access Macedonian Journal of Medical Sciences 10, B (20 de abril de 2022): 1093–96. http://dx.doi.org/10.3889/oamjms.2022.9021.
Texto completoKim, Junhyung, Min Woo Park, Young Joon Park, Ju Won Ahn, Jeong Min Sim, Suwan Kim, Jinhyung Heo et al. "miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells". Genes 12, n.º 5 (23 de abril de 2021): 633. http://dx.doi.org/10.3390/genes12050633.
Texto completoKim, Junhyung, Min Woo Park, Ju Won Ahn, Jeong Min Sim, Suwan Kim, Young Joon Park, Jinhyung Heo et al. "TAMI-47. MIR-542-3P CONTRIBUTES TO THE HK2-MEDIATED HIGH GLYCOLYTIC PHENOTYPE IN HUMAN GLIOMA CELLS". Neuro-Oncology 23, Supplement_6 (2 de noviembre de 2021): vi208. http://dx.doi.org/10.1093/neuonc/noab196.830.
Texto completoTran Anh Duc, Nguyen Thanh Bac, Nguyen Van Ba y Nguyen Duc Lien. "Study on some clinical features, histopathology and mutations in IDH, P53 genes, mgmt methylation in patients with high-grade glioma". VietNam Military Medical Unisversity 47, n.º 6 (8 de septiembre de 2022): 191–99. http://dx.doi.org/10.56535/jmpm.v47i6.66.
Texto completoVattemi, Emanuela, Giovanna Cipollini, Cristina Dealis, Lorena Rossi, Susanne Baier, Elisabetta Cretella, Giovanni Di Meglio et al. "Genetic polymorphisms of EGF 5'-UTR in patients with glioma: A possible predictive marker of outcome." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): e13009-e13009. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e13009.
Texto completoBracci, Paige, Terri Rice, Helen Hansen, Stephen Francis, Sean Lee, Lucie McCoy, Pavan Shrestha et al. "EPID-08. PRE-SURGERY IMMUNE PROFILES OF ADULT GLIOMA PATIENTS". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii79—ii80. http://dx.doi.org/10.1093/neuonc/noaa215.326.
Texto completoLi, D., Y. Chen, C. Guo, Q. Yang, S. Wu, Y. Xia, J. Zeng et al. "P03.09 Real world management and prognosis of glioma patients:SYSUCC report from China". Neuro-Oncology 21, Supplement_3 (agosto de 2019): iii26—iii27. http://dx.doi.org/10.1093/neuonc/noz126.090.
Texto completoBai, Ya-hui, Yun-bo Zhan, Bin Yu, Wei-Wei Wang, Li Wang, Jin-qiao Zhou, Ruo-kun Chen et al. "A Novel Tumor-Suppressor, CDH18, Inhibits Glioma Cell Invasiveness Via UQCRC2 and Correlates with the Prognosis of Glioma Patients". Cellular Physiology and Biochemistry 48, n.º 4 (2018): 1755–70. http://dx.doi.org/10.1159/000492317.
Texto completoJadus, Martin, Neil Hoa, Lisheng Ge, Yurii Kuznetsov, Alex McPherson, Andrew Cornforth, Nabil Ahmed y Lawrence Lamb. "Gliomas display complex cell surface topographies that resist cytolytic lymphocytes but are reversed by using fascin siRNA (48.2)". Journal of Immunology 186, n.º 1_Supplement (1 de abril de 2011): 48.2. http://dx.doi.org/10.4049/jimmunol.186.supp.48.2.
Texto completoRen, Jinhong, Peilan Jia, Hongxia Feng, Xiuhua Li, Jinghui Zhao y Yunxia Sun. "Involvement of poly(ADP-ribose) polymerase-1 in Chinese patients with glioma: a potential target for effective patient care". International Journal of Biological Markers 33, n.º 1 (27 de julio de 2017): 68–72. http://dx.doi.org/10.5301/ijbm.5000267.
Texto completoAabedi, alexander, Benjamin Lipkin, Jasleen Kaur, Sofia Kakaizada, Jacob Young, Anthony Lee, Saritha Krishna, Edward Chang, David Brang y Shawn Hervey-Jumper. "TAMI-66. FUNCTIONAL ALTERATIONS IN CORTICAL PROCESSING OF SPEECH IN GLIOMA-INFILTRATED CORTEX". Neuro-Oncology 23, Supplement_6 (2 de noviembre de 2021): vi212. http://dx.doi.org/10.1093/neuonc/noab196.848.
Texto completoHu, Guangdong, Fengyuan Qian, Longgui Sha y Zilong Wei. "Application of Deep Learning Technology in Glioma". Journal of Healthcare Engineering 2022 (18 de febrero de 2022): 1–9. http://dx.doi.org/10.1155/2022/8507773.
Texto completoCheng, Ling-Gang, Wen He, Hong-Xia Zhang, Qian Song, Bin Ning, Hui-Zhan Li, Yan He y Song Lin. "Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma". BioMed Research International 2016 (2016): 1–9. http://dx.doi.org/10.1155/2016/2643862.
Texto completoSun, Jin-Zhang, Jin-Hao Zhang, Jia-Bo Li, Feng Yuan, Lu-Qing Tong, Xu-Ya Wang, Lu-Lu Chen et al. "MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma". Disease Markers 2021 (9 de junio de 2021): 1–13. http://dx.doi.org/10.1155/2021/6680883.
Texto completoSriwidyani, Ni Putu, Ida Ayu Ika Wahyuniari, Herman Saputra y I. Gusti Kamasan Nyoman Arijana. "IDH1 mutation in Balinese glioma patients and its relationship with clinicopatological parameters". Bali Medical Journal 9, n.º 3 (1 de diciembre de 2020): 819–22. http://dx.doi.org/10.15562/bmj.v9i2.2077.
Texto completoWatts, Colin, Alimu Dayimu, Tomasz Matys, Keyoumars Ashkan, Stephen Price, Michael D. Jenkinson, Gail Doughton et al. "Refining the Intraoperative Identification of Suspected High-Grade Glioma Using a Surgical Fluorescence Biomarker: GALA BIDD Study Report". Journal of Personalized Medicine 13, n.º 3 (13 de marzo de 2023): 514. http://dx.doi.org/10.3390/jpm13030514.
Texto completoXuan, Chengmin, Mingwei Jin, Lei Wang, Shengbai Xue, Qi An, Qingzeng Sun, Lei Wang y Yong Gao. "PART1 and hsa-miR-429-Mediated SHCBP1 Expression Is an Independent Predictor of Poor Prognosis in Glioma Patients". BioMed Research International 2020 (13 de abril de 2020): 1–12. http://dx.doi.org/10.1155/2020/1767056.
Texto completoMellinghoff, Ingo K., Benjamin M. Ellingson, Mehdi Touat, Elizabeth Maher, Macarena I. De La Fuente, Matthias Holdhoff, Gregory M. Cote et al. "Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma". Journal of Clinical Oncology 38, n.º 29 (10 de octubre de 2020): 3398–406. http://dx.doi.org/10.1200/jco.19.03327.
Texto completoWang, Zengliang, Yirizhati Aili, Yongxin Wang, Nuersimanguli Maimaitiming, Hu Qin, Wenyu Ji, Guofeng Fan y Bo Li. "The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma". Oxidative Medicine and Cellular Longevity 2022 (9 de agosto de 2022): 1–28. http://dx.doi.org/10.1155/2022/7967722.
Texto completoGao, Huasong, Bin Yu, Yaohua Yan, Jianhong Shen, Sanhu Zhao, Jianhong Zhu, Wenxin Qin y Yilu Gao. "Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis". Journal of Neurosurgery 118, n.º 4 (abril de 2013): 846–53. http://dx.doi.org/10.3171/2012.9.jns112134.
Texto completoQi, Ying, Xinyu Yang, Chunxia Ji, Chao Tang y Liqian Xie. "Identification of an IL-4-Related Gene Risk Signature for Malignancy, Prognosis and Immune Phenotype Prediction in Glioma". Brain Sciences 12, n.º 2 (29 de enero de 2022): 181. http://dx.doi.org/10.3390/brainsci12020181.
Texto completoHajri, Rami, Marie Nicod-Lalonde, Andreas F. Hottinger, John O. Prior y Vincent Dunet. "Prediction of Glioma Grade and IDH Status Using 18F-FET PET/CT Dynamic and Multiparametric Texture Analysis". Diagnostics 13, n.º 15 (5 de agosto de 2023): 2604. http://dx.doi.org/10.3390/diagnostics13152604.
Texto completoSabedot, Thais S., Tathiane M. Malta, James Snyder, Kevin Nelson, Michael Wells, Ana C. deCarvalho, Abir Mukherjee et al. "A serum-based DNA methylation assay provides accurate detection of glioma". Neuro-Oncology 23, n.º 9 (9 de febrero de 2021): 1494–508. http://dx.doi.org/10.1093/neuonc/noab023.
Texto completoMitsuka, Kentaro, Tomoyuki Kawataki, Eiji Satoh, Takayuki Asahara, Toru Horikoshi y Hiroyuki Kinouchi. "Expression of Indoleamine 2,3-Dioxygenase and Correlation With Pathological Malignancy in Gliomas". Neurosurgery 72, n.º 6 (19 de febrero de 2013): 1031–39. http://dx.doi.org/10.1227/neu.0b013e31828cf945.
Texto completoJoe, Dorothy, Jose Lavrador, Francesco Vergani, Richard Gullan, Ranjeev Bhangoo, Keyoumars Ashkan y Gerald Finnerty. "033 Audit on the diagnostic pathway of patients with glioma mimics". Journal of Neurology, Neurosurgery & Psychiatry 90, n.º 12 (14 de noviembre de 2019): A18.4—A19. http://dx.doi.org/10.1136/jnnp-2019-abn-2.60.
Texto completoWang, Jialin, Zhendong Liu, Cheng Zhang, Hongbo Wang, Ang Li, Binfeng Liu, Xiaoyu Lian et al. "Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients". PeerJ 9 (8 de febrero de 2021): e10820. http://dx.doi.org/10.7717/peerj.10820.
Texto completoCheng, Tong, Manyu Xu, Hui Zhang, Bing Lu, Xiaojing Zhang, Ziheng Wang y Jianfei Huang. "KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma". Oxidative Medicine and Cellular Longevity 2022 (19 de septiembre de 2022): 1–14. http://dx.doi.org/10.1155/2022/2694377.
Texto completoLim, Jaejoon, Youngjoon Park, Minjun Kim, Juwon Ahn, KyuBum Kwack y Kyunggi Cho. "TMIC-03. UPREGULATION OF THE NLRC4 INFLAMMASOME CONTRIBUTES TO POOR PROGNOSIS IN GLIOMA PATIENTS". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi247. http://dx.doi.org/10.1093/neuonc/noz175.1037.
Texto completoden Hartog, Sanne J., Anja van der Kolk, Annette Bruggink, Tatjana Seute, Pieter Wesseling y Joyce Wilbers. "Pathology-proven extradural (“distant”) metastases of gliomas in adults in the Netherlands between 1971 and 2018: a systematic case series". Neuro-Oncology Practice 8, n.º 3 (22 de enero de 2021): 317–24. http://dx.doi.org/10.1093/nop/npab006.
Texto completoNguyen, Anthony V., Jose M. Soto, Sarah-Marie Gonzalez, Jennifer Murillo, Eric R. Trumble, Frank Y. Shan y Jason H. Huang. "H3G34-Mutant Gliomas—A Review of Molecular Pathogenesis and Therapeutic Options". Biomedicines 11, n.º 7 (15 de julio de 2023): 2002. http://dx.doi.org/10.3390/biomedicines11072002.
Texto completoRiviere-Cazaux, C. y T. Burns. "OS01.6.A Through the Looking Glass: CSF Proteomics for Glioma Monitoring and Response Assessment". Neuro-Oncology 24, Supplement_2 (1 de septiembre de 2022): ii10. http://dx.doi.org/10.1093/neuonc/noac174.031.
Texto completoCinarer, Gokalp y Bulent Gursel Emiroglu. "Classification of brain tumours using radiomic features on MRI". New Trends and Issues Proceedings on Advances in Pure and Applied Sciences, n.º 12 (30 de abril de 2020): 80–90. http://dx.doi.org/10.18844/gjpaas.v0i12.4989.
Texto completoKadiyala, Padma, Felipe Nunez, Maria Garcia-Fabiani, Fernando Nunez, Dan Li, Anna Schwendeman, Pedro Lowenstein y Maria Castro. "IMMU-03. SUPPRESSION OF ONCOMETABOLITE 2-HYDROXYGLUTRATE PRODUCED BY MUTANT IDH1 GLIOMA WITH AGI-5198 ENHANCES THE EFFICACY OF RADIOTHERAPY AND IMMUNE CHECKPOINT BLOCKADE ELICITING IMMUNOLOGICAL MEMORY". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi119. http://dx.doi.org/10.1093/neuonc/noz175.497.
Texto completoGuo, Lydia, Ryan Rilinger, Akshay Sharma, Mina Lobbous y Matthew Grabowski. "SDPS-45 PROGNOSTIC CHARACTERIZATION OF GENETIC MARKERS IN GLIOMA-ASSOCIATED EPILEPSY". Neuro-Oncology Advances 5, Supplement_3 (1 de agosto de 2023): iii25. http://dx.doi.org/10.1093/noajnl/vdad070.099.
Texto completoFries, Georg, Axel Perneczky y Oliver Kempski. "Glioblastoma-associated circulating monocytes and the release of epidermal growth factor". Journal of Neurosurgery 85, n.º 4 (octubre de 1996): 642–47. http://dx.doi.org/10.3171/jns.1996.85.4.0642.
Texto completoYeo, Kee Kiat, Sanda Alexandrescu, Chantel Cacciotti, Emily Krzykwa, Jessica Clymer, Christine Chordas, Mary Ann Zimmerman, Susan Chi, Katherine Warren y Karen Wright. "LGG-03. INCIDENCE AND OUTCOME OF PEDIATRIC IDH-MUTANT GLIOMA". Neuro-Oncology 22, Supplement_3 (1 de diciembre de 2020): iii366—iii367. http://dx.doi.org/10.1093/neuonc/noaa222.388.
Texto completoWang, Hesong, Yanyan Feng, Yuxiang Zhang, Ting Wang, Heng Xu, Yuxing Zhi, Yuyin Feng, Lichun Tian y Kai Yuan. "Siglec10—An immunosuppressor and negative predictor of survival prognosis in gliomas". Frontiers in Genetics 13 (16 de noviembre de 2022). http://dx.doi.org/10.3389/fgene.2022.873655.
Texto completoZhou, Kaijia, Tao Jiang, Yanwei Liu, Zheng Zhao, Lijie Huang y Guanzhang Li. "FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide". BMC Neurology 21, n.º 1 (9 de noviembre de 2021). http://dx.doi.org/10.1186/s12883-021-02476-2.
Texto completoSprugnoli, Giulia, Laura Rigolo, Meghan Faria, Parikshit Juvekar, Yanmei Tie, Simone Rossi, Nicola Sverzellati, Alexandra J. Golby y Emiliano Santarnecchi. "Glioma BOLD connectivity profile and its relationship to patients’ survival". Neuro-Oncology Advances, 25 de septiembre de 2022. http://dx.doi.org/10.1093/noajnl/vdac153.
Texto completoZhu, Hua, Xinyao Hu, Shi Feng, Lijuan Gu, Zhihong Jian, Ning Zou y Xiaoxing Xiong. "Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients". Frontiers in Immunology 13 (15 de julio de 2022). http://dx.doi.org/10.3389/fimmu.2022.946692.
Texto completoLv, Kun, Xin Cao, Rong Wang, Peng Du, Junyan Fu, Daoying Geng y Jun Zhang. "Neuroplasticity of Glioma Patients: Brain Structure and Topological Network". Frontiers in Neurology 13 (13 de mayo de 2022). http://dx.doi.org/10.3389/fneur.2022.871613.
Texto completoLiu, Fangkun, Jing Huang, Xuming Liu, Quan Cheng, Chengke Luo y Zhixiong Liu. "CTLA-4 correlates with immune and clinical characteristics of glioma". Cancer Cell International 20, n.º 1 (6 de enero de 2020). http://dx.doi.org/10.1186/s12935-019-1085-6.
Texto completoGe, Honglin, Guangfu Di, Zheng Yan, Dongming Liu, Yong Liu, Kun Song, Kun Yang et al. "Does epilepsy always indicate worse outcomes? A longitudinal follow-up analysis of 485 glioma patients". World Journal of Surgical Oncology 20, n.º 1 (19 de septiembre de 2022). http://dx.doi.org/10.1186/s12957-022-02772-2.
Texto completoLiu, Li-qiang, Li-fei Feng, Cheng-rui Nan y Zong-mao Zhao. "CREB3L1 and PTN expressions correlate with prognosis of brain glioma patients". Bioscience Reports 38, n.º 3 (22 de mayo de 2018). http://dx.doi.org/10.1042/bsr20170100.
Texto completoLiu, Zhendong, Wang Zhang, Xingbo Cheng, Hongbo Wang, Lu Bian, Jialin Wang, Zhibin Han et al. "Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients". Molecular Medicine 27, n.º 1 (29 de mayo de 2021). http://dx.doi.org/10.1186/s10020-021-00316-0.
Texto completoChen, Chia-Hua, Kuo-Chen Wei, Wei-Chao Liao, You-Yu Lin, Hsiu-Chi Chen, Li-Ying Feng, Chiung-Hui Liu et al. "Prognostic value of an APOBEC3 deletion polymorphism for glioma patients in Taiwan". Journal of Neurosurgery, 1 de septiembre de 2022, 1–13. http://dx.doi.org/10.3171/2022.7.jns2250.
Texto completoZhang, Hao, Jialin He, Ziyu Dai, Zeyu Wang, Xisong Liang, Fengqiong He, Zhiwei Xia et al. "PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas". Frontiers in Immunology 12 (16 de febrero de 2021). http://dx.doi.org/10.3389/fimmu.2021.628966.
Texto completo